Literature DB >> 7510312

Utility of gram stain in evaluation of sputa from patients with cystic fibrosis.

E Sadeghi1, A Matlow, I MacLusky, M A Karmali.   

Abstract

The utility of sputum Gram stain in assessing salivary contamination and in predicting the presence of pathogens on the basis of morphology was investigated in 287 respiratory specimens from patients with cystic fibrosis. Where acceptability for culture was defined as a leukocyte/squamous epithelial cell ratio of > 5, 76.6% (220 of 287) of respiratory specimens received in the laboratory were considered acceptable. Unacceptable specimens were more common in younger patients. The positive predictive value of the Gram stain for growth from acceptable sputum samples was 98% for Pseudomonas aeruginosa, 84.4% for Pseudomonas cepacia, 86.3% for Staphylococcus aureus, and 100% for Haemophilus influenzae. In cystic fibrosis patients, as has been reported for respiratory specimens in general, Gram stain of respiratory specimens in helpful for interpreting culture results.

Entities:  

Mesh:

Year:  1994        PMID: 7510312      PMCID: PMC262969          DOI: 10.1128/jcm.32.1.54-58.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Microscopic and baceriologic analysis of expectorated sputum.

Authors:  P R Murray; J A Washington
Journal:  Mayo Clin Proc       Date:  1975-06       Impact factor: 7.616

2.  A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.

Authors:  R C Hubbard; N G McElvaney; P Birrer; S Shak; W W Robinson; C Jolley; M Wu; M S Chernick; R G Crystal
Journal:  N Engl J Med       Date:  1992-03-19       Impact factor: 91.245

3.  Microscopic and bacteriological comparison of paired sputa and transtracheal aspirates.

Authors:  R W Geckler; D H Gremillion; C K McAllister; C Ellenbogen
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

4.  Bacterial sputum cultures. A clinician's viewpoint.

Authors:  R E Van Scoy
Journal:  Mayo Clin Proc       Date:  1977-01       Impact factor: 7.616

5.  Acceptability and cost savings of selective sputum microbiology in a community teaching hospital.

Authors:  H S Heineman; R R Radano
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

6.  Accuracy of Gram's stain in identifying pneumococci in sputum.

Authors:  M F Rein; J M Gwaltney; W M O'Brien; R H Jennings; G L Mandell
Journal:  JAMA       Date:  1978-06-23       Impact factor: 56.272

7.  Ordering patterns, collection, transport, and screening of sputum cultures in a community hospital: evaluation of methods to improve results.

Authors:  J T Jacobson; J P Burke; J A Jacobson
Journal:  Infect Control       Date:  1981 Jul-Aug

Review 8.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

9.  Abnormal morphology of bacteria in the sputa of patients treated with antibiotics.

Authors:  V Lorian; A Waluschka; Y Kim
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

10.  Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.

Authors:  M R Hammerschlag; L Harding; A Macone; A L Smith; D A Goldmann
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

View more
  7 in total

1.  Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.

Authors:  M Kolpen; T Bjarnsholt; C Moser; C R Hansen; L F Rickelt; M Kühl; C Hempel; T Pressler; N Høiby; P Ø Jensen
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

2.  Usefulness of Gram stain for diagnosis of lower respiratory tract infection or urinary tract infection and as an aid in guiding treatment.

Authors:  E J Kuijper; J van der Meer; M D de Jong; P Speelman; J Dankert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-25       Impact factor: 3.267

3.  Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota.

Authors:  Amanda F Goddard; Benjamin J Staudinger; Scot E Dowd; Amruta Joshi-Datar; Randall D Wolcott; Moira L Aitken; Corinne L Fligner; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-07       Impact factor: 11.205

4.  Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.

Authors:  P W Whitby; H L Dick; P W Campbell; D E Tullis; A Matlow; T L Stull
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

5.  Utility of gram staining for evaluation of the quality of cystic fibrosis sputum samples.

Authors:  Bindu Nair; Jenny Stapp; Lynn Stapp; Linda Bugni; Jill Van Dalfsen; Jane L Burns
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

Review 6.  Diagnostic test for etiologic agents of community-acquired pneumonia.

Authors:  John G Bartlett
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

7.  Comparison of methods for the analysis of airway macrophage particulate load from induced sputum, a potential biomarker of air pollution exposure.

Authors:  Hannah Jary; Jamie Rylance; Latifa Patel; Stephen B Gordon; Kevin Mortimer
Journal:  BMC Pulm Med       Date:  2015-11-05       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.